Prognostic value of the QRS duration in patients with heart failure: A subgroup analysis from 24 centers of Val-HeFT

Journal of Cardiac Failure

Volumn 11, Issue 7, 2005, Pages 523-528

  Hofmann, Monika ^a   Bauer, Ricarda ^a   Handrock, Renate ^b   Weidinger, Gottfried ^b   Goedel Meinen, Liselotte ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NOVARTIS PHARMA GMBH   (Germany)

Author keywords

Electrocardiography; Heart failure; Prognosis

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; VALSARTAN; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUDDEN DEATH; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOMYOPATHIES; CORONARY DISEASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; GERMANY; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 25844483741     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.03.008     Document Type: Article

References (28)

1. G.S. Francis Determinants of prognosis in patients with heart failure J Heart Lung Transplant 13 Suppl 1994 S113 S116
2. J.N. Cohn Val-HeFT (Valsartan Heart Failure Trial) Clin Cardiol 24 2001 86
3. J.N. Cohn, G. Tognoni, R.D. Glazer, D. Spormann, and on behalf of the Val-HeFT Investigators Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure J Card Fail 5 1999 155 160
4. J. Coromilas Classification of antiarrhythmic agents: electropharmacologic basis and clinical relevance Cardiovasc Clin 22 1992 97 116
5. P.J. Cowburn, J.G.F. Cleland, A.J.S. Coats, and M. Komajda Risk stratification in chronic heart failure Eur Heart J 19 1998 696 710
6. J.G. Cleland, H.J. Dargie, and I. Ford Mortality in heart failure: clinical variables of prognostic value Br Heart J 58 1987 572 582
7. S. Goldman, G. Johnson, J.N. Cohn, G. Cintron, R. Smith, and G. Francis Mechanism of death in heart failure: The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group Circulation 87 Suppl VI 1993 24 31
8. C.V. Hughes, M. Wong, G. Johnson, J.N. Cohn, and for the V-HeFT VA Cooperative Studies Group Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group Circulation 87 Suppl VI 1993 111 117
9. T.L. Kelly, R. Cremo, C. Nielsen, and R. Shabetai Prediction of outcome in late-stage cardiomyopathy Am Heart J 119 1990 1111 1121
10. M.J. Likoff, S.L. Chandler, and H.R. Kay Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy Am J Cardiol 59 1987 634 638
11. D.M. Mancini, K.L. Wong, and M.B. Simson Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy Circulation 87 1993 1083 1092
12. D.V. Unverferth, R.D. Magorien, and M.L. Moeschberger Factors influencing the one-year mortality of dilated cardiomyopathy Am J Cardiol 54 1984 147 152
13. V.K. Gottipaty, S.P. Krelis, F. Lu, and V. Shusternan The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure J Am Coll Cardiol 33 1999 145A
14. Y. Koga, T. Wada, H. Toshima, K. Akazawa, and Y. Nose Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy Heart Vessels 8 1993 37 41
15. W. Shamim, D.P. Francis, M. Yousufuddin, S. Varney, M.F. Dieopli, and S.D. Anker Intraventricular conduction delay: a prognostic marker in chronic heart failure Int J Cardiol 70 1999 171 178
16. H.B. Xiao, C. Roy, S. Fujimoto, and D. Gibson Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy Int J Cardiol 53 1996 163 170
17. M.I. Anastasiou-Nana, J.N. Nanas, L.A. Karagounis, E.P. Tsagalou, G.E. Alexopoulos, and S. Toumanidis Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality Am J Cardiol 85 2000 1212 1217
18. S. Cazeau, C. Leclercq, T. Lavergne, S. Walker, C. Varma, and C. Linde Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880
19. H.B. Xiao, C. Roy, and D.G. Gibson Nature of ventricular activation in patients with dilated cardiomyopathy: evidence for bilateral bundle branch block Br Heart J 72 1994 167 174
20. C. Stellbrink, A. Auricchio, B. Diem, O.A. Breithardt, M. Kloss, and F.A. Schöndube Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia Am J Cardiol 83 1999 143D 150D
21. H.J. Shenkman, J.E. McKinnon, A.K. Khandelwal, V. Pampati, D.M. Nori, and P.A. McCullough Determinants of QRS prolongation in a generalized heart failure population: findings from the CONQUEST Study Circulation 102 Suppl II 2000 617
22. T. Taneja, B.W. Mahnert, R. Passman, J. Goldberger, and A. Kadish Effects of sex and age on electrocardiographic and cardiac electrophysiological properties in adults Pacing Clin Electrophysiol 24 2001 16 21
23. M.E. Silverman, M.D. Pressel, J.C. Brackett, S. Lauria, M.R. Gold, and S.S. Gottlieb Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy Am J Cardiol 5 1995 460 464
24. H. Tabuchi, N. Kawai, and T. Sawayama Estimation of left ventricular systolic function based on the electrocardiograms in cases with left bundle branch block J Cardiol 31 1998 23 30
25. M. Castro, R. Descamps, and J.A. Thomis Electrocardiographic changes after long-term treatment with sotalol in hypertensive patients Int J Clin Pharmacol Ther Toxicol 20 1982 88 91
26. C. Blomstrom-Lundqvist, M. Dohnal, I. Hirsch, A. Lindblad, A. Hjalmarson, and S.B. Olson Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing Br Heart J 55 1986 181 186
27. J.M. Starr, and L.J. Whalley Hypertensive Old People in Edinburgh (HOPE) Study: electrocardiographic changes after captopril or bendrofluazide treatment Age Ageing 22 1993 343 348
28. J.L. Vacek, L.R. Handlin, C.J. Beaufort, and C.A. Koenig Effects of angiotensin-converting enzyme inhibitor therapy on presence of late potentials detected using signal-averaged electrocardiography in patients with congestive heart failure Coron Artery Dis 4 1993 1109 1113